The FDA approved the first pharmacological drug for the treatment of presbyopia in October 2021. Vuity from Allergan is a once-daily 1.25% pilocarpine HCL ophthalmic solution with pHast technology.
The GEMINI 1 and GEMINI 2 phase 3 clinical studies showed a three line or more gain in mesopic, high-contrast, binocular distance corrected near visual acuity at day 30, hour 3 without losing more than five letters in corrected distance visual acuity with the same refractive correction. GEMINI 1 even made statistical significance at hour 6, day 30. Both studies had (Read more...)